Compound ID | 919
Anthracimycin
Synonym(s): CNH365 | CNH365.396
Class: Small molecule antibacterial agent
| Agent Type: | Natural product; Small molecule; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against Staphylococcus aureus including methicillin-resistant strains and Moraxella catarrhalis |
| Description: | Hensler M, Soubih E, Jang K, et al. CNH365.396, a novel marine-derived compound with potent activity against methicillin resistant Staphylococcus aureus(MRSA). 50th-ICAAC 2012. |
| Institute where first reported: | Trius Therapeutics (Merck & Co., USA) |
| Year first mentioned: | 2012 |
| Highest development stage: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citation: | https://doi.org/10.1002/anie.201302749 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.